Translating Biology Into Breakthroughs
At InVivo Biosystems, we’re redefining what’s possible in preclinical discovery. Our RapidGen™ platform combines conserved biology, advanced genetics, and whole-organism models to deliver decision-ready insights that accelerate the path from question to breakthrough.
Our Mission
To empower scientists with advanced genetic tools and custom in vivo models that accelerate discovery, improve human health, and bring life-saving therapies to market faster.
Our Vision
A future where every disease has a precise model, every researcher has the tools they need, and scientific breakthroughs move at the speed of life.
“We trace the threads between fundamental discovery and therapeutic breakthroughs, turning what nature has preserved across species into real hope for patients seeking cures today.”
-Kat McCormick, CEO
2010
Year Established
23
Avg. Years of Experience in Genetics
31
Employees
4000+
Preclinical Models Created
11
PhDs on Staff
280+
Publications
Driving Innovation Through Expertise & Experience
For over a decade, InVivo Biosystems has been at the forefront of genetic research, pioneering breakthroughs in disease modeling and preclinical drug testing.
From Founders to Frontiers: A History of Innovation
University of Oregon Professors Shawn Lockery and Janis Weeks developed the first user-friendly and scalable electrophysiology platform for nematodes.
From Founders to Frontiers: A History of Innovation
NemaMetrix was one of the five finalists who received the award under the Obama Administration.
From Founders to Frontiers: A History of Innovation
NemaMetrix adds the capability of creating custom CRISPR transgenics by joining forces with Knudra Transgenics, a pioneer and an expert in gene editing capabilities.
From Founders to Frontiers: A History of Innovation
The company adds the capability of creating genetic models using zebrafish for understanding gene function, basic biology, and more precisely modeling human diseases.
From Founders to Frontiers: A History of Innovation
The company launches analytical services to produce data and insights for companies to de-risk preclinical development.
From Founders to Frontiers: A History of Innovation
The company adds phenotypic assay technologies specifically tailored to CNS diseases, such as epilepsy.
From Founders to Frontiers: A History of Innovation
The company builds out a comprehensive drug discovery and development platform and identifies a set of lead therapeutics for the treatment of a variety of diseases.
From Founders to Frontiers: A History of Innovation
The company appoints new executive level leaders and sets forth a new strategic vision for the journey of the RapidGen™ platform.
Collaborating Across Scientific Frontiers
We work with scientists and teams across a broad range of sectors.
Biotech & Pharma
Speed up your preclinical pipeline with validated in vivo models.
Academic Institutions
Support for grant projects, novel model development, and student training.
Startups & CROs
Flexible genetic tools tailored to rapid research timelines.
Get in Touch
Partner with us to accelerate your research and bring innovation to the forefront of genetic discovery.